Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
300630 Hainan Poly Pharm
27.530-0.730-2.58%
Market Close
01/20 15:00 CCT
High
28.400
Open
28.140
Turnover
136.52M
Low
27.450
Pre Close
28.260
Volume
49.23Klot
Price Forecast
News
Comment
Puli Pharmaceutical: announcement on the trading of foreign exchange derivatives by the company and its wholly-owned subsidiaries
Puli Pharmaceutical: announcement on the proposed establishment of a wholly-owned subsidiary
Puli Pharmaceutical: announcement on the use of some idle funds raised to purchase wealth management products due for redemption
Puli Pharmaceutical: announcement on the approval of Okazepine tablets to be listed in Germany by Zhejiang Puli Pharmaceutical Co., Ltd.
Puli Pharmaceutical: announcement on the signing of a strategic cooperation framework agreement between Zhejiang Puli Pharmaceutical Co., Ltd., a wholly-owned subsidiary, and Shanghai Gusen Pharmaceutical Co., Ltd.
Puli Pharmaceutical: announcement on the CEP Certificate of magnesium hydroxide Raw Drug of Anhui Puli Pharmaceutical Co., Ltd., a wholly-owned subsidiary
Puli Pharmaceutical: announcement on receipt of FDA notification letter for cyclophosphamide raw materials in Anhui Puli Pharmaceutical Co., Ltd., a wholly owned subsidiary.
Puli Pharmaceutical: announcement that Anhui Puli Pharmaceutical Co., Ltd., a wholly owned subsidiary, has obtained the project record.
Puli Pharmaceutical: announcement on receipt of FDA notification letter for gadolinium meglumine raw materials in Anhui Puli Pharmaceutical Co., Ltd.
Puli Pharmaceutical: announcement on the completion of Industrial and Commercial Registration of wholly-owned Sun Company
Company Overview
More
The company was founded in 1992 and is a high-tech enterprise specializing in R&D, production and sales of chemical formulations. It has been certified as a leading enterprise in the internationalization of pharmaceutical formulations in China. The company is a high-tech enterprise specializing in drug research and development, registration, production and sales. The products sold by the company are mainly prescription drugs, covering the fields of anti-allergic drugs, non-steroidal analgesic and anti-inflammatory drugs, antibiotics, digestive drugs, etc. Corporate honors: “Development and production transformation of enteric sodium diclofenate enteric slow-release capsules” project won the second prize in science and technology in Hainan Province, the “development and industrialization of dry desloratadine suspensions” project won the third prize of science and technology in Hainan Province, “fubiding (desloratadine dry suspension)” was rated as an outstanding product in the pharmaceutical industry in Hainan Province by the Hainan Pharmaceutical Industry Association. Desloratadine dispersion tablets and desloratadine dry suspensions won the “28th National Pharmaceutical Economic Information Conference” in 2016 A list of 2 brands for hospital terminals and primary terminals in the China Pharmaceutical/Brand List (anti-allergic drug category).
CEO： --
Market： --
Listing Date： 03/28/2017
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet